Recently approved recombinant factor VIII (rFVIII) for the replacement treatment in patients with hemophilia A in Italy. (2017). Farmeconomia. Health Economics and Therapeutic Pathways, 18(1). https://doi.org/10.7175/fe.v18i1.1321